We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Hey everybody, Dave Bartosiak with Trending Stocks at Zacks.com. I am always amazed when a bank gets banged for a billion dollars. They talk so much about risk and preservation of capital. Banks are supposed to be safe, and conservative. Navy suits with brown wing-tips driving Toyota Camry’s and taking coffee in the breakroom to pinch a penny.
Then you have Credit Suisse, asleep at the wheel again, set to take billions in losses from Archegos. Add this one to the Luckin Coffee crash, questionable SoftBank deals, a $450 million hit from York Capital, and the Greensill Capital crunch earlier this month. That’s all just since December. I’m pretty sure CEO Thomas Gottstein is eating spoonfuls of Tums for breakfast.
This latest loss stems from Bill Hwang’s private investment firm, Archegos Capital Management, receiving one of the largest margin calls of all-time. You want to see a dead body?
I’ve got four for you, ViacomCBS , Discovery , GSX Techedu , and Baidu (BIDU - Free Report) . Let’s take a look on Zacks.com to see what I mean.
The recent action on all these stocks has been absolutely terrible. Look at GSX first. This is a stock that popped up to $149.05 on January 27th. By mid-March, it was already down to the low $90s. If you thought that was bad, the stock has since tumbled all the way down to the low $30s where it’s trading at on March 30th despite a 6% bounce.
So which of these stocks is the value? Which one is in the good graces of our Zacks Rank?
Both ViacomCBS and Baidu are currently Zacks Rank #3 (Hold) stocks.
Every time you share this video, a big bank loses a billion dollars. Follow the author, subscribe to the YouTube channel, twitter @bartosiastics, and check out Zacks.com/promo for our special report on 7 biotech stocks. For Trending Stocks with Zacks.com, I’m Dave Bartosiak.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better. See these 7 breakthrough stocks now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Stocks to Buy on Archegos Dip
Hey everybody, Dave Bartosiak with Trending Stocks at Zacks.com. I am always amazed when a bank gets banged for a billion dollars. They talk so much about risk and preservation of capital. Banks are supposed to be safe, and conservative. Navy suits with brown wing-tips driving Toyota Camry’s and taking coffee in the breakroom to pinch a penny.
Then you have Credit Suisse, asleep at the wheel again, set to take billions in losses from Archegos. Add this one to the Luckin Coffee crash, questionable SoftBank deals, a $450 million hit from York Capital, and the Greensill Capital crunch earlier this month. That’s all just since December. I’m pretty sure CEO Thomas Gottstein is eating spoonfuls of Tums for breakfast.
This latest loss stems from Bill Hwang’s private investment firm, Archegos Capital Management, receiving one of the largest margin calls of all-time. You want to see a dead body?
I’ve got four for you, ViacomCBS , Discovery , GSX Techedu , and Baidu (BIDU - Free Report) . Let’s take a look on Zacks.com to see what I mean.
The recent action on all these stocks has been absolutely terrible. Look at GSX first. This is a stock that popped up to $149.05 on January 27th. By mid-March, it was already down to the low $90s. If you thought that was bad, the stock has since tumbled all the way down to the low $30s where it’s trading at on March 30th despite a 6% bounce.
So which of these stocks is the value? Which one is in the good graces of our Zacks Rank?
Both ViacomCBS and Baidu are currently Zacks Rank #3 (Hold) stocks.
Every time you share this video, a big bank loses a billion dollars. Follow the author, subscribe to the YouTube channel, twitter @bartosiastics, and check out Zacks.com/promo for our special report on 7 biotech stocks. For Trending Stocks with Zacks.com, I’m Dave Bartosiak.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>